294 related articles for article (PubMed ID: 33916908)
21. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
22. Role of the Nrf2 signaling system in health and disease.
Hybertson BM; Gao B
Clin Genet; 2014 Nov; 86(5):447-52. PubMed ID: 25099075
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.
Zhou Y; Li Y; Ni HM; Ding WX; Zhong H
Toxicol Appl Pharmacol; 2016 Nov; 310():140-149. PubMed ID: 27639429
[TBL] [Abstract][Full Text] [Related]
24. The role of Nrf2 in oxidative stress-induced endothelial injuries.
Chen B; Lu Y; Chen Y; Cheng J
J Endocrinol; 2015 Jun; 225(3):R83-99. PubMed ID: 25918130
[TBL] [Abstract][Full Text] [Related]
25. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
26. MITF Modulates Therapeutic Resistance through EGFR Signaling.
Ji Z; Erin Chen Y; Kumar R; Taylor M; Jenny Njauw CN; Miao B; Frederick DT; Wargo JA; Flaherty KT; Jönsson G; Tsao H
J Invest Dermatol; 2015 Jul; 135(7):1863-1872. PubMed ID: 25789707
[TBL] [Abstract][Full Text] [Related]
27. LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance.
Billing O; Holmgren Y; Nosek D; Hedman H; Hemmingsson O
Oncogene; 2021 May; 40(21):3707-3718. PubMed ID: 33947959
[TBL] [Abstract][Full Text] [Related]
28. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
Gordon-Thomson C; Jones J; Mason RS; Moore GP
Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways.
Namani A; Liu K; Wang S; Zhou X; Liao Y; Wang H; Wang XJ; Tang X
Aging (Albany NY); 2019 Dec; 11(24):12600-12623. PubMed ID: 31884422
[TBL] [Abstract][Full Text] [Related]
30. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A.
Pajares M; Rojo AI; Arias E; Díaz-Carretero A; Cuervo AM; Cuadrado A
Autophagy; 2018; 14(8):1310-1322. PubMed ID: 29950142
[TBL] [Abstract][Full Text] [Related]
32. Early induction of NRF2 antioxidant pathway by RHBDF2 mediates rapid cutaneous wound healing.
Hosur V; Burzenski LM; Stearns TM; Farley ML; Sundberg JP; Wiles MV; Shultz LD
Exp Mol Pathol; 2017 Apr; 102(2):337-346. PubMed ID: 28268192
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.
Alam MM; Okazaki K; Nguyen LTT; Ota N; Kitamura H; Murakami S; Shima H; Igarashi K; Sekine H; Motohashi H
J Biol Chem; 2017 May; 292(18):7519-7530. PubMed ID: 28314773
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
[TBL] [Abstract][Full Text] [Related]
35. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.
Ivanov VN; Hei TK
Oncogene; 2005 Jan; 24(4):616-26. PubMed ID: 15580309
[TBL] [Abstract][Full Text] [Related]
36. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways.
Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T
Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537
[TBL] [Abstract][Full Text] [Related]
37. NRF2-dependent stress defense in tumor antioxidant control and immune evasion.
Friedmann Angeli JP; Meierjohann S
Pigment Cell Melanoma Res; 2021 Mar; 34(2):268-279. PubMed ID: 33205526
[TBL] [Abstract][Full Text] [Related]
38. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.
Namani A; Li Y; Wang XJ; Tang X
Biochim Biophys Acta; 2014 Sep; 1843(9):1875-85. PubMed ID: 24851839
[TBL] [Abstract][Full Text] [Related]
39. Sigma 1 receptor regulates the oxidative stress response in primary retinal Müller glial cells via NRF2 signaling and system xc(-), the Na(+)-independent glutamate-cystine exchanger.
Wang J; Shanmugam A; Markand S; Zorrilla E; Ganapathy V; Smith SB
Free Radic Biol Med; 2015 Sep; 86():25-36. PubMed ID: 25920363
[TBL] [Abstract][Full Text] [Related]
40. Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY.
Bendavit G; Aboulkassim T; Hilmi K; Shah S; Batist G
J Biol Chem; 2016 Dec; 291(49):25476-25488. PubMed ID: 27784786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
